Osteogenesis imperfecta
• Inheriteddefect in collagen synthesis
• Osteopenia and brittle bones
• Often- defective tooth formation, blue
sclera, faulty hearing
• Inheritance can be dominant, recessive or
by new mutation
• Several degrees of severity
Achondroplasia
• Involves adefect in normal cartilage
development
• Epiphyseal plates close early in long bones;
individual has short arms and legs, but
normal spine and skull
• Dominant inheritance, but frequent new
mutations
• Other organs develop normally
• Individuals live a normal lifespan
Osteopetrosis
Osteopetrosis, also knownas marble bone disease, refers
to a group of rare genetic diseases that are characterized
by reduced bone resorption and diffuse symmetric
skeletal sclerosis resulting from impaired formation or
function of osteoclasts.
The term osteopetrosis refects the stonelike quality of the
bones. However, the bones are abnormally brittle and
fracture easily, like a piece of chalk.
Osteopetrosis is classifed into variants based on both the
mode of inheritance and the severity of clinical fndings.
9.
Acquired diseases ofbone development
• Osteoporosis
• Paget disease
• Rickets and osteomalacia
• Hyperparathyroidism
• Renal Osteodystrophy
10.
Osteoporosis “porous bone”
•Most common metabolic bone disease in North
America
• Can be attributed to genetics, diet or hormones
• Most osteoporosis is idiopathic osteoporosis
• Bone loss due to an identifiable cause is secondary
osteoporosis
• Bone tissue is mineralized normally, but over time
the structural integrity of bone is lost and it
becomes thinner and weaker, and more prone to
fractures.
11.
• Key features:bone fracture and the associated pain.
• WHO defines osteoporosis by bone density:
• Normal bone > 833 mg/cm2
• Osteopenia 833 to 648 mg/cm2
• Osteoporosis < 648 mg/cm2
• Can be generalized, involving major portions of the
axial skeleton
• Can be regional, involving one segment of the
appendicular skeleton
11
• Remodeling isconstant
• Teen years more bone is laid down than reabsorbed
• Peak bone mass or maximum density reached at around
30 years of age
• After age 30, bone is reabsorbed faster than it is laid
down
• In women, bone loss is most rapid in the first years after
menopause, but continues throughout postmenopausal
years
• Est. 55% of people over 50 have osteoporosis or low bone
mass.
13
14.
• Men alsolose bone density, but start out with more
bone mass so takes longer.
• By age 90 about 17% of males have had a hip
fracture, vs. 32 % of females
• Vertebral fractures also occur → kyphosis
• Most common in whites, but affects all races.
• African Americans have about half the fracture rates
of whites (higher peak bone mass)
14
Risk factors
• Familyhistory
• White race
• Increased age
• Female sex
• Small stature
• Fair or pale skin
• Thin build
• Early menopause (natural or surgical)
• Late menarche 22
23.
Risk factors cont.
•Nulliparity
• Obesity
• Weight below a healthy range
• Acidosis
• Low dietary calcium and vitamin D
• High caffeine intake
• Sedentary life style
• Smoker
• Excessive alcohol consumption
• Liver, kidney disease, rheumatoid arthritis, etc.
23
24.
• Often progressessilently for decades until
fracture occurs
• Bones can fracture spontaneously
• Most severe in spine, wrist and hips
• Estrogens and androgens may be factors in
both sexes
• Testosterone is converted into estrogen in
peripheral tissues and decreases bone loss
• Rapid bone loss is osteoclast mediated
• Slow bone loss is osteoblast mediated 24
25.
Clinical manifestations
• Painand bone deformity
• Kyphosis caused by vertebral collapse
• Fractures of long bones
• Fatal complications include fat or pulmonary
embolism, pneumonia, hemorrhage and shock
• 20 % die as a result of surgical complications
26.
Prevention
• Intake ofcalcium, vitamin D, magnesium and
possibly boron
• Regular, weight-bearing exercise
• Avoid tobacco and glucocorticoids
• No alcoholism
• Hormone replacement?
• Parathyroid hormone?
• Testosterone for men and possibly women
27.
Pagets disease(OsteitisDeformans):
• Characterizedby repetitive episodes of frenzied,
regional osteoclastic activity and bone resorption
(osteolytic stage), followed by exuberant bone
formation (mixed osteoclastic-osteoblastic stage), and
finally by an apparent exhaustion of cellular activity
(osteosclerotic stage). The net effect of this process is
a gain in bone mass; however, the newly formed bone
is disordered and lacks strength.
• Bone enlargementand thickening
• Increased osteo-clast/blast activity > increased
turnover
• Aet - unknown but racial difference ?viral
• CF - M=F, >50, ache but not severe unless fracture or
tumour
• Investigation - X-ray appearance is characteristic,
alkaline phophatase is increased and hydroxyproline
in urine is increasded
• Rx - bisphos, calcitonin
30.
Rickets and Osteomalacia
•Inadequate mineral deposition in essentially
normal organic matrix
• Softened bone:
• Subject to malformation and distortion –
pain
30
31.
Rickets
• Dietary vitaminD deficiency causes
inadequate mineralization of the developing
skeleton in infants and children
• Rarely seen in Western nations
• Poverty
• Ignorance
• Bones are soft and easily deformed
• Tendency to fractures
• Therapy: suppliment vitamin D and calcium 31
32.
Osteomalacia
• Rarely dueto vitamin D deficiency
• Usually GI malabsorption, renal defect or
chronic kidney or liver diseases.
• Elderly often affected due to inadequate diet
or lack of outdoor activity
• May accompany and complicate osteoporosis.
32
Normal bone metabolism
•CALCIUM
99% in bone.
Main functions - muscle/nerve
function, clotting. Plasma calcium - 50% free,
50% bound to albumin.
• Dietary needs-
Kids- 600mg/day,
Adolesc.-1300mg/day,
Adult-750mg/day,
Pregnancy-
1500mg/day,
Breastfeeding-2g/day,
Fractures- 1500mg/day
• Absorbed in duodenum (active transport) and
jejunum (diffusion), 98% reabsorbed in kidney
prox. tubule, may be excreted in stool.
35.
Normal bone metabolism
•PHOSPHATE
85% in bone.
Functions -
metabolite and buffer in enzyme systems.
• Plasma phosphate mainly unbound.
Daily requirement
1-1.5g/day
36.
Regulation of Calciumand Phosphate Metabolism:
Peak bone mass at 16-25 years.
Bone loss 0.3- 0.5% per year (2-3% per year after 6th
decade).
1. Parathyroid Hormone (PTH)
2. Vitamin D3
3. Calcitonin
4. Other Hormones:
Estrogen: Prevents bone loss
Corticosteroids: Increases bone loss
Thyroid hormones:
Leads to osteoporosis
Growth hormones: Cause positive calcium balance
Growth factors
RICKETS, OSTEOMALACIA
PATHOLOGY:
Sufficient osteoid,poor mineralization
RICKETS is found only in children prior to the
closure of the growth plates, while
OSTEOMALACIA occurs in persons of any age.
Any child with rickets also has osteomalacia, while the
reverse is not necessarily true.
41.
CAUSES:
1. Nutritional deficiency
1.Vit D
2. chelators of calcium- phytates, oxalates, phosphorous
3. Antacid abuse, causing reduced dietary phosphate
binding
2. GI absorption defects
1. Post gastrectomy
2. Biliary disease (reduced absorption of Vitamins )
3. Small bowel disease
4. liver disease
3. Renal tubular defects
4. Renal osteodystrophy
5. Miscellaneous causes
42.
CLINICAL FEATURES:
• Rickets-
Tetany , convulsions, failure to thrive,
Restlessness, muscular flaccidity.
Flattening & softening of skull (craniotabes),
Thickening of wrists from epiphyseal overgrowth,
Stunted growth,
Rickety rosary, spinal curvature,
Coxa vara, bowing, # of long bones
• Osteomalacia –
Aches and pains, muscle weakness, loss of height,
stress #s.
XRAY FINDINGS:
OSTEOMALACIA
Loosers zones- incomplete
stress # with healing lacking
calcium, on compression side
of long bones.
Codfish vertebrae due to
pressure of discs
Trefoil pelvis(Triangular), due
to indentation of acetabulae
stress #s
46.
INVESTIGATIONS:
BLOOD TESTS
Calcium Reduced,
Phosphatereduced
Alkalline Phosphatase increased
Urinary excretion of calcium diminished
Calcium phosphate products (= serum [Ca] x serum [PO4])
normally 30. In rickets and osteomalacia is less than 24
47.
MANAGEMENT:
Depends on thecause
Nutritional
Vitamin D deficiency
Dietary chelators of calcium
Phytates
Oxalates
Phosphorus deficiency (unusual)
Antacid abuse
Treatment- vitamin D (5000u) and Calcium (3g/day)
48.
MANAGEMENT:
Depends on thecause
Renal Osteodystrophy – in chronic renal failure
Miscellaneous
Hypophosphatasia
Anticonvulsant therapy
SURGERY
For deformities
Vitamin D resistant (familial hypophosphatemic rickets)
Treatment; Phosphate 1-3 gm daily, Vit D3 high dose
49.
Factors affecting boneturnover
• PTH and calcitonin
• Oestrogen
• gut - increased absorption
• bone - decreased re-absorption
• Glucocorticoids
• gut - decrease absorption
• bone - increased re-absorption/decreased formation
• Thyroxine
• stimulates formation/resorption
• net resorption
50.
Bone metabolic disorders
Presentation?
•Skeletal abnormality
• osteopenia - osteomalacia/osteoporosis
• osteitis fibrosa cystica - replacement of bone with
fibrous tissue usually due to PTH excess
• Hypercalcaemia
• Underlying hormonal disorder
When to investigate?
• Under 50
• repeated fractures or deformity
• systemic features or signs of hormonal disorder
51.
Hyperparathyroidism
• Excessive PTH
•Due to prim (adenoma), sec (hypocalc), tert
(second hyperact -> autonomous overact)
• Osteitis due to fibr repl of bone
• Clin feat - hypercalc
• Invest - Calcium incr, PO4 decr, incr PTH
• Rx surgery
52.
Renal osteodystrophy
Combination of
•osteomalacia
• secondary PTH increase (osteitis fibrosa)
• osteoporosis/sclerosis
• CF - renal disorder, depends on
predominant pathology
• Rx - vit D or 1,25-DHCC
• renal disorder correction
#19 This MRI of the spine demonstrates marked kyphosis with compressed fractures. Such a finding can be seen as a consequence of osteoporosis.
#20 Here is a "compressed" fracture of the vertebral column. The middle vertebral body shown here is greatly reduced in size. Such fractures are common in persons with osteoporosis in which there is accelerated bone loss, particularly older women, and can occur with even minor trauma.